NSC-139021产品是NSC-139021 (ERGi-USU) is a highly selective inhibitor for the growth of ERG-positive cancer cells with IC₅₀s ranging from 30 to 400 nM. NSC-139021 displays minimal effect on normal prostate or endothelial cells or ERG-negative tumor cell lines.